Albert Bourla, AP
Covid-19 roundup: CanSino eyes more overseas PhIII sites as Canada trial reportedly stalls; Indian drugmaker surges on 30-person data
Having leveraged connections in Canada for a planned Phase III trial of its Covid-19 vaccine, CanSino is venturing out to a few more others as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
